Copy
EuropaBio Newsletter 24-28 February

 
HEADLINES
The European Healthcare industry calls for balanced and transparent funding of the EU pharmacovigilance system
EuropaBio, EFPIA, EGA, AESGP and EUCOPE (the industry), support the implementation of an effective pharmacovigilance system to ensure patient safety and recognise recent efforts which have been made to ensure greater fairness, proportionality and transparency in some aspects of the proposals for the mechanism of fees to be paid to the European Medicines Agency (EMA) for these Pharmacovigilance activities.Read more

Gene and Cell Therapy Funding Opportunities in Horizon 2020
Since 1984, the European Commission has undertaken seven framework programs (FPs), dedicated to research and innovation, that ran for 5–7-year periods.Read here an overview of eighth research and innovation program and find out its potential for growth and its role in Horizon 2020.Read more

GMO crops should have consumer focus - Sainsbury CEO
British consumers will only embrace genetically modified foods when traits are developed which provide them with significant benefits, In order to embrace the change that GM birngs, there needs to be a focus on informing the consumer .Read more


 

Healthcare Biotech

Parliament adopts third health programme for 2014-2020

The new Programme will advance the objectives of the Europe 2020 Strategy by fostering health as an indispensable condition for smart, sustainable and inclusive growth.Read more 
 

Industry concern over EU pharmacovigilance fees

The main trade associations that represent Europe's healthcare industry have called for "balanced and transparent funding" of the continent's pharmacovigilance system.Read more
 

Stem Cell Therapy Offers Groundbreaking Treatment for Parkinson’s Disease

While there is no known cure, new developments in regenerative medicine are now offering an alternative treatment option for people who suffer from Parkinson’s Disease. Find out here how this cutting-edge technique can help those who suffer from this chronic, debilitative and progressive movement disorder.Read more

Agricultural Biotech

Stephane Le Foll opens the door to the second generation of GMOs

The Minister of Agriculture wants to launch a debate on the possible exploitation of second generation GMOs.Watch the video where he answers question on imports, non GMO production and other topics.Read more (art in French)

Greece seeks greater flexibility ahead of debate on GM crops
Greece is pleading with environment ministers from the member states to be more flexible ahead of a debate on genetically modified crops on Monday,3 March.Find out why Member states are divided over whether the European Union should authorise GM crops for cultivation.Read more 
 

GMO debate on RTE (min 21:14)

Listen here to a insightful debate on GM food and the latest in the growing constituency of interest in genetically modified (GM) crops in Europe.Read more

Industrial Biotech

Biofuels made from rubbish 'could power 16% of EU road transport

Fuel made from waste could replace 16% of all the fuel used on European roads by 2030, cutting spending on oil imports and boosting the rural economy by up to €15bn, according to a joint report by industry and NGOs.Read more

The global production of bioplastics will be able to grow by 400% in 2016
The current global production capacity of bioplastics, including both biodegradable and bio-based plastics is about 1.5 million tonnes, which supposes a total revenue of about 4,400 million Euros.  Find out here why the bioplastic sector shows such potential and what are the future goals to be achieved.Read more


 

SMEs
 

Biovision 2014 Conference

The selection platforms both for Biovision Catalyzer and Biovision Investor Conference are now open, bringing together international decision-makers from the academic, private, political and civil society sectors, its purpose is to transform innovative ideas into actionable solutions for the benefit of citizens.Read more
 

EVENTS
Copyright © 2014 EuropaBio, All rights reserved.